Lobby organisation
Boehringer Ingelheim
Business / industry · Health & pharma · HQ: Germany · Transparency Register entry
As of 9 September 2026, Boehringer Ingelheim appears in 37 declared MEP meetings (31 different MEPs), most often with European People's Party.
In their own words
“Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 37 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (15 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 10 Mar 2026 | Jörgen Warborn | International trade |
| 10 Mar 2026 | Tomislav Sokol | Health Policy |
| 10 Mar 2026 | Wouter Beke | How the EU can strengthen its attractiveness for long-term investment in the pharmaceutical sector, to the benefit of patients and Europe’s competitiveness |
| 13 Jan 2026 | Ingeborg ter Laak | EU Cardiovascular Health Plan, CMA & Biotech Act |
| 4 Dec 2025 | Christine Singer | Tiergesundheit |
| 5 Nov 2025 | Angelika Winzig | Meeting with representatives of Boehringer Ingelheim & Pharmig |
| 5 Nov 2025 | Marta Temido | Papel do Parlamento Europeu nas areas da saúde |
| 5 Nov 2025 | Lukas Mandl | Most Favored Nation Executive Order, Critical Medicines Act, EU Pharma Legislation |
| 5 Nov 2025 | Bruno Gonçalves | ITRE policies |
| 5 Nov 2025 | Andreas Glück | Health |
| 4 Nov 2025 | Maria Walsh | Animal disease |
| 4 Nov 2025 | Stefan Köhler | Politischer Austausch zum Thema Tierseuchen |
| 4 Nov 2025 | Sophia Kircher | Chemicals Omnibus, EU-US relations |
| 4 Nov 2025 | Asger Christensen | Boehringer Ingelheim Danmark A/S |
| 4 Nov 2025 | Laurent Castillo | Pharma |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.